Company intelligence / Profile preview

Chardan Healthcare Acquisition 2

New York, New York, United States

Ownership: Private
Employees: ~2
Development stage: Other

Overview

Chardan Healthcare Acquisition 2 Corp. was a healthcare‑focused special purpose acquisition company (SPAC) that completed a business combination with gene therapy company Renovacor in September 2021 and ceased to exist as an independent listed entity; the combined company was renamed Renovacor and began trading on the NYSE under the ticker RCOR.[1][2][4][11]

Industry: Investors

Partnerships

Chardan Capital Markets (sponsor and advisor)

Beyond the preview

Go deeper on Chardan Healthcare Acquisition 2.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chardan Healthcare Acquisition 2.

Explore the full profile